In this program, Dr. Lorenzo Rossaro, Chief of UC Davis Hepatology, introduces a newly FDA approved therapy for Hepatitis C. Series: "UC Grand Rounds"
telaprevir-incivek, boceprevir-victrelis
This blog is all about current FDA approved drugs to treat the hepatitis C virus (HCV) with a focus on treating HCV according to genotype, using information extracted from peer-reviewed journals, liver meetings/conferences, and interactive learning activities.
No comments:
Post a Comment